3 completed, 1 active not recruiting, 1 enrolling by invitation, 1 not yet recruiting. 3 Not applicable, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Enrolling by invitation 1, Not yet recruiting 1, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Recruiting 1 |
Follow Schizophrenia and Schizoaffective Disorder: new trials by email Literature Review of Schizophrenia and Schizoaffective Disorder trials Research Report on Schizophrenia and Schizoaffective Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia Deferiprone (DFP), N-Acetyl Cysteine (NAC) - Schizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder | Phase 2 | Recruiting | Amit Lotan | 80 | 2026-08-12 | 2026-09-29 |
| Effects of RAS in SZ RAS incorporated in upper-limb movement training, Upper-limb movement training - Schizophrenia and Schizoaffective Disorder | Not applicable | Not yet recruiting | Shu-Mei Wang | 140 | 2025-08-01 | 2025-07-25 |
| A Trial of Group Cognitive Behavioral Therapy for Psychosis (the Feeling Safe Programme) Cognitive Behavioral Therapy for Psychosis - Schizophrenia and Schizoaffective Disorder | Not applicable | Enrolling by invitation | The Royal Ottawa Mental Health Centre | 50 | 2024-08-16 | 2026-08-12 |
| Relationship Between Physical Fitness and Psychopathology, Cognition and Quality of Life in Patients Diagnosed With Schizophrenia: a Mixed Method Study. Schizophrenia and Schizoaffective Disorder | Active not recruiting | Universidade da Coruña | 45 | 2024-03-19 | 2025-02-13 | |
| Survey on the Reproductive and Child-Rearing Situations of Patients With Severe Mental Disorders Schizophrenia and Schizoaffective Disorder, Bipolar Disorder (BD) | Completed | Peking University | 77145 | 2021-06-07 | 2025-06-05 | |
| D-Serine Treatment For Tardive Dyskinesia D-serine, Placebo - Schizophrenia and Schizoaffective Disorder, Tardive Dyskinesia | Not applicable | Unknown | Herzog Hospital | 16 | 2013-01-01 | 2018-10-11 |
| Switch Study of Existing Atypical Antipsychotics to Bifeprunox Aripiprazole, Olanzapine, Risperidone - Schizophrenia and Schizoaffective Disorder | Phase 3 | Completed | Solvay Pharmaceuticals | 286 | 2006-12-01 | 2008-05-21 |
| A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices Aripiprazole - Schizophrenia and Schizoaffective Disorder | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 400 | 2005-03-01 | 2013-11-08 |
Psychotic Disorders (8) · Schizophrenia (8) · Bipolar Disorder (1) · Tardive Dyskinesia (1)
Mental Disorders (8) · Schizophrenia Spectrum and Other Psychotic Disorders (8) · Bipolar and Related Disorders (1) · Central Nervous System Diseases (1) · Dyskinesia, Drug-Induced (1) · Dyskinesias (1) · Mood Disorders (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Aripiprazole (2) · Acetylcysteine (1) · Cognitive Behavioral Therapy (1) · Deferiprone (1) · Olanzapine (1) · Quetiapine Fumarate (1) · Risperidone (1) · ziprasidone (1)
Amit Lotan (1) · Herzog Hospital (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1) · Peking University (1) · Shu-Mei Wang (1) · Solvay Pharmaceuticals (1) · The Royal Ottawa Mental Health Centre (1) · Universidade da Coruña (1)
Canada (2) · Israel (2) · Argentina (1) · China (1) · Czechia (1) · Estonia (1) · France (1) · Hungary (1) · Latvia (1) · Lithuania (1) · Spain (1) · Taiwan (1) · United States (1)
Deanna Mercer, M.D. (1) · Lisa Murata, BScN, MEd (1) · Uriel Heresco-Levy, MD (1)